The safety of the cyclophilin A inhibitor Debio 025 is uncertain due to cardiac issues in a clinical trial. — Whalespan
The safety of the cyclophilin A inhibitor Debio 025 is uncertain due to cardiac issues in a clinical trial.
⚠ High risk
We can't find evidence that holds up here. Proponents are reasoning from mechanism or analogy rather than direct human data, and the most credible skeptics raise objections we can't dismiss.
✕NOTSUPPORTED
⚠
High-risk intervention — consult a physician before acting.Drug-drug interactions, dose-dependence, and screening contraindications apply.
“is it safe so first of all I wouldn't say it's safe so they had been um few clinical trials and unfortunately some of them have been stopped and I think it was for a design for Hepatitis C yeah it's also currently used by the way it has been used a year ago for kovi 90. in France or to to Canada for the long people having very long like a lot of long information uh things like that I think but I again I haven't checked recently but I know the they stopped the trial for one person that had some cardiac issues after the treatment so I cannot say it's safer it's not safe”
Conflict Watch
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.